#USA #Boston #LifeSphere #ArisGlobal #NavaX

ArisGlobal Unveils NavaX Translation: A Game Changer in Global Pharmacovigilance

ArisGlobal, an innovative leader in AI technology within the life sciences sector and the creator of the LifeSphere® platform, recently introduced a groundbreaking solution named NavaX Translation. This announcement, made through a partnership with TransPerfect Life Sciences, aims to transform the way global pharmacovigilance teams manage translation processes.

In the current landscape of pharmacovigilance, teams are inundated with safety reports submitted in various languages. Traditionally, these processes involve manual exports, liaising with third-party vendors, and time-consuming re-imports into safety systems. These delays not only hinder efficiency but also pose risks to compliance in a highly regulated environment. NavaX Translation seeks to resolve these issues efficiently.

Intelligent Language Detection and Translation

One of the standout features of NavaX Translation is its sophisticated language detection capability. This system automatically identifies non-English safety forms and rapidly routes them for certified translation. Utilizing pharma-specific AI models and expert human translators from TransPerfect ensures that all translated materials meet the rigorous standards required in life sciences. Through seamless integration via API, translated forms and data are quickly returned to LifeSphere Safety, reducing the hours of manual labor previously required to just minutes.

Key Benefits of NavaX Translation

NavaX Translation is carefully crafted for regulated life sciences settings, blending the efficiency of AI with the linguistic expertise of professional translators. Here are the main advantages it offers:

• - Automated Multilingual Intake: Quick and easy identification of languages within safety reports.
• - Certified Translations: Ensures high-quality output through pharmaceutical-specific models and expert linguists.
• - Seamless API Integration: Eliminates the need for manual exports and re-imports, simplifying workflows.
• - Compliance-Ready Output: Fully supports global regulatory requirements, ensuring that all translations are up to standard.
• - Scalable Operations: Designed to handle the demands of high-volume, multi-market case processing.

A Vision for the Future

Jason Bryant, Senior Vice President of AI and Data Product Management at ArisGlobal, emphasized the company’s commitment to integrating intelligent automation into critical workflows. He stated, “By partnering with TransPerfect, we are able to deliver translations that not only meet quality and compliance benchmarks but also facilitate a smoother operational workflow.”

The launch of NavaX Translation further reinforces the ongoing success of the NavaX platform, which is processing over 1 million safety cases, with projections to hit 2.5 million by mid-2026. Performance metrics for NavaX also highlight a remarkable data accuracy rate exceeding 95% and efficiency gains of over 30%, illustrating the tangible return on investment for users.

Kevin Obarski, Chief Growth Officer at TransPerfect, adds, “Our collaboration with ArisGlobal allows us to embed validated translation into a truly intelligent safety platform. This partnership enables life sciences organizations to scale confidently on a global level while ensuring compliance with all regulatory standards.”

Available to LifeSphere Safety customers starting July 2026, NavaX Translation promises to redefine how safety reports are handled across different languages.

For further information about NavaX Translation, visit NavaX Translation | ArisGlobal.

About ArisGlobal

ArisGlobal stands at the forefront of life sciences technology, revolutionizing how prominent companies develop innovations and launch new products. Based in the United States with additional offices worldwide, it remains committed to delivering cutting-edge solutions to address the unique challenges of the life sciences industry.

About TransPerfect Life Sciences

TransPerfect Life Sciences specializes in facilitating the global development and commercialization of critical drugs and medical devices. Their comprehensive service offerings include eTMF and eClinical technologies, pharmacovigilance solutions, and high-quality translation services, enabling clients to achieve impactful global launches.